This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Catalano, A. Articles by Procopio, A. Search for Related Content PubMed PubMed Citation Articles by Catalano, A. Articles by Procopio, A.

(American Journal of Pathology. 2001;159:721-731.)
© 2001 American Society for Investigative Pathology

Regular Articles

Methionine Aminopeptidase-2 Regulates Human Mesothelioma Cell Survival

Role of Bcl-2 Expression and Telomerase Activity

Alfonso Catalano^*, Mario Romano, Iole Robuffo, Luigi Strizzi and Antonio Procopio^*

From the Department of Experimental Pathology,^*
University of Ancona, Ancona; the Department of Human Pathology,
University of Messina, Messina; the Institute of Normal and Pathological Cytomorphology,
National Research Council, Chieti; and the Department of Oncology and Neuroscience,
Clinical Pathology Section, G. D’Annunzio University, Chieti, Italy

Methionine aminopeptidase-2 (MetAP2) is the molecular target of the angiogenesis inhibitors, fumagillin and ovalacin. Fumagillin can also inhibit cancer cell proliferation, implying that MetAP2 may play a quite complex role in tumor progression. Here, we examined the expression and function of MetAP2 in an in vitro model of human mesothelioma. We found that mesothelioma cells expressed higher MetAP2 mRNA levels than primary normal mesothelial cells. Consistently, fumagillin induced apoptosis, owing to early mitochondrial damage, in malignant, but not in normal mesothelial cells. Transfection of mesothelioma cells with a MetAP2 anti-sense oligonucleotide determined a time-dependent inhibition of cell survival and induced nucleosome formation. Interestingly, mRNA and protein levels of the anti-apoptotic gene bcl-2 as well as telomerase activity were selectively reduced after MetAP2 inhibition in mesothelioma cells, whereas bcl-2 overexpression counteracted the effect of MetAP2 inhibition on telomerase activity and apoptosis. MetAP2 inhibition also increased caspase activity and the caspase inhibitor, zVAD-fmk, prevented fumagillin-induced apoptosis, but it did not alter telomerase activity. These results indicate that MetAP2 is a main regulator of proliferative and apoptotic pathways in mesothelioma cells and suggest that MetAP2 inhibition may represent a potential target for therapeutic intervention in human mesothelioma.

This article has been cited by other articles:

				M. S. Redell, A. Tsimelzon, S. G. Hilsenbeck, and D. J. Tweardy Conditional overexpression of Stat3{alpha} in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern J. Leukoc. Biol., October 1, 2007; 82(4): 975 - 985. [Abstract] [Full Text] [PDF]

				D. Kass, R. S. Bridges, A. Borczuk, and S. Greenberg Methionine Aminopeptidase-2 as a Selective Target of Myofibroblasts in Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 193 - 201. [Abstract] [Full Text] [PDF]

				A. C. Cooper, R. M. Karp, E. J. Clark, N. R. Taghizadeh, J. G. Hoyt, M. T. Labenski, M. J. Murray, G. Hannig, W. F. Westlin, and C. D. Thompson A Novel Methionine Aminopeptidase-2 Inhibitor, PPI-2458, Inhibits Non-Hodgkin's Lymphoma Cell Proliferation In vitro and In vivo Clin. Cancer Res., April 15, 2006; 12(8): 2583 - 2590. [Abstract] [Full Text] [PDF]

				B. Dasgupta, Y. Yi, B. Hegedus, J. D. Weber, and D. H. Gutmann Cerebrospinal Fluid Proteomic Analysis Reveals Dysregulation of Methionine Aminopeptidase-2 Expression in Human and Mouse Neurofibromatosis 1-Associated Glioma Cancer Res., November 1, 2005; 65(21): 9843 - 9850. [Abstract] [Full Text] [PDF]

				M. J. Morowitz, R. Barr, Q. Wang, R. King, N. Rhodin, B. Pawel, H. Zhao, S. A. Erickson, G. S. Sheppard, J. Wang, et al. Methionine Aminopeptidase 2 Inhibition Is an Effective Treatment Strategy for Neuroblastoma in Preclinical Models Clin. Cancer Res., April 1, 2005; 11(7): 2680 - 2685. [Abstract] [Full Text] [PDF]

				S. Ross, C. Giglione, M. Pierre, C. Espagne, and T. Meinnel Functional and Developmental Impact of Cytosolic Protein N-Terminal Methionine Excision in Arabidopsis Plant Physiology, February 1, 2005; 137(2): 623 - 637. [Abstract] [Full Text] [PDF]

				H. Nakagawa, S. Koyanagi, T. Takiguchi, Y. Kuramoto, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo 24-Hour Oscillation of Mouse Methionine Aminopeptidase2, a Regulator of Tumor Progression, Is Regulated by Clock Gene Proteins Cancer Res., November 15, 2004; 64(22): 8328 - 8333. [Abstract] [Full Text] [PDF]

				A. Catalano, S. Rodilossi, M. R. Rippo, P. Caprari, and A. Procopio Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma Cells J. Biol. Chem., November 5, 2004; 279(45): 46706 - 46714. [Abstract] [Full Text] [PDF]

				P. Selvakumar, A. Lakshmikuttyamma, R. Kanthan, S. C. Kanthan, J. R. Dimmock, and R. K. Sharma High Expression of Methionine Aminopeptidase 2 in Human Colorectal Adenocarcinomas Clin. Cancer Res., April 15, 2004; 10(8): 2771 - 2775. [Abstract] [Full Text] [PDF]

				J. Wang, G. S. Sheppard, P. Lou, M. Kawai, N. BaMaung, S. A. Erickson, L. Tucker-Garcia, C. Park, J. Bouska, Y.-C. Wang, et al. Tumor Suppression by a Rationally Designed Reversible Inhibitor of Methionine Aminopeptidase-2 Cancer Res., November 15, 2003; 63(22): 7861 - 7869. [Abstract] [Full Text] [PDF]